Share of adolescent girls vaccinated against human papillomavirus in France
France: Share of adolescent girls vaccinated against human papillomavirus was 45.0% in 2024. ▲ Rising
Share of adolescent girls vaccinated against human papillomavirus in France, 2010–2024
Source: WHO & UNICEF (2025) – processed by Our World in Data. Measured in %.
Analysis
The most recent figure for share of adolescent girls vaccinated against human papillomavirus in France is 45.0%, measured in 2024. That is the highest value across all 15 years on record.
The figure is up 246.2% over ten years.
Over the whole period, share of adolescent girls vaccinated against human papillomavirus in France peaked at 45.0% in 2022 and was at its lowest, 13.0%, in 2014.
France ranks 59th of 74 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 15 years of available data.
Share of adolescent girls vaccinated against human papillomavirus in France, year by year
| Year | % | Change |
|---|---|---|
| 2010 | 25.0% | — |
| 2011 | 22.0% | -12.0% |
| 2012 | 17.0% | -22.7% |
| 2013 | 16.0% | -5.9% |
| 2014 | 13.0% | -18.8% |
| 2015 | 20.0% | +53.8% |
| 2016 | 21.0% | +5.0% |
| 2017 | 24.0% | +14.3% |
| 2018 | 24.0% | +0.0% |
| 2019 | 33.0% | +37.5% |
| 2020 | 37.0% | +12.1% |
| 2021 | 42.0% | +13.5% |
| 2022 | 45.0% | +7.1% |
| 2023 | 45.0% | +0.0% |
| 2024 | 45.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 21.5% | 13.0% | 33.0% | 10 |
| 2020s | 42.8% | 37.0% | 45.0% | 5 |
Countries ranked near France
- 56 Solomon Islands 51.0% compare
- 57 Guyana 48.0% compare
- 57 Micronesia (country) 48.0% compare
- 60 South Africa 44.0% compare
- 61 Palau 43.0% compare
- 62 Armenia 41.0% compare
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.42 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0793 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.49 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.083 units per person (2025)
Frequently asked questions
- What is share of adolescent girls vaccinated against human papillomavirus in France?
- Share of adolescent girls vaccinated against human papillomavirus in France was 45.0% in 2024, according to WHO & UNICEF (2025) – processed by Our World in Data.
- What is the highest share of adolescent girls vaccinated against human papillomavirus recorded in France?
- The highest recorded value was 45.0% in 2022.
- What is the lowest share of adolescent girls vaccinated against human papillomavirus recorded in France?
- The lowest recorded value was 13.0% in 2014.
- How does France rank for share of adolescent girls vaccinated against human papillomavirus?
- France ranks 59th out of 74 countries with data for 2024.
- Is share of adolescent girls vaccinated against human papillomavirus rising or falling in France?
- Over the last ten years it is up 246.2%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from WHO & UNICEF (2025) – processed by Our World in Data, published as part of Share of adolescent girls vaccinated against human papillomavirus. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.